Article

CIBA Vision opens Singapore production facility

Singapore—CIBA Vision has opened a multi-million-dollar contact lens and lens care manufacturing facility at Tulas Biomedical Park here, where it will employ 220 people now and 500 in the future.

Singapore-CIBA Vision has opened a multi-million-dollar contact lens and lens care manufacturing facility at Tulas Biomedical Park here, where it will employ 220 people now and 500 in the future.

The company has invested $85 million of the total $250 million it plans to spend on the project.

Mike Dilworth, vice president, global supply chain, for CIBA Vision, said the plant will serve as the company's Asia-Pacific supply chain hub for the global market and serve as a warehouse and distribution center for manufacturing activities in the region. It will supply Focus Dailies daily disposable soft contact lenses to the Asian market and O2OPTIX, produced in Batam, for the global market.

In other news, CIBA Vision appointed George Minno, PhD, as global head of lens care research and development. Dr. Minno will be responsible for bringing new lens care solutions to development. He joins the company from Alimera Sciences Inc., where he was vice president of product development, and he previously worked for CIBA Vision and Novartis Ophthalmics in technical and marketing positions.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) NeuroOp Guru: Cranial nerve six palsy with chemosis is a critical clue to cavernous carotid fistula
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.